MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Peripheral Synucleinopathy in Essential Tremor Plus Patients with Parkinsonian Features and Normal Dopamine Transporter Imaging

VG. Evidente, T. Levine, D. Evidente, R. Freeman, C. Gibbons (Scottsdale, USA)

Meeting: 2023 International Congress

Abstract Number: 968

Keywords: Alpha-synuclein, Essential tremor(ET), Synucleinopathies

Category: Tremor

Objective: To describe results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) in patients with essential tremor (ET) with parkinsonism.

Background: Patients with longstanding ET may develop subtle parkinsonian signs, most commonly a rest tremor. Elderly ET patients may present with parkinsonism due to advanced age or orthopedic issues. ET patients have increased risk of developing Parkinson’s disease (PD) compared to the normal population. ET patients who develop parkinsonism or other motor/nonmotor symptoms are referred to as ET-Plus. The dopamine transporter (DaT) scan is often performed to differentiate between ET with parkinsonism (ET-P) and PD, as it is normal in ET and abnormal in PD. Skin biopsy for P-SYN is positive in PD, multiple system atrophy (MSA) or dementia with lewy bodies (DLB), and negative in ET. The frequency of peripheral synucleinopathy in ET-P is unknown.

Method: We did a retrospective review of all ET-P patients seen in one center from 2012-2023 who had undergone P-SYN skin biopsy. The main reason for skin biopsy was presence of parkinsonian sign(s). We reviewed demographic data, presence of RBD, extrapyramidal exam, autonomic symptoms, DaT scan, cardiac MIBG scan, and University of Pennsylvania Smell Identification Test (UPSIT).

Results: We identified 24 patients with ET-P who had skin biopsy for P-SYN. 16/24 (67%) were men. 17/24 (71%) had a rest tremor. 7/24 (29%) had RBD. 15/24 (62%) had 2 or more autonomic symptoms. Average age at time of biopsy was 69.75 years (range=30-88). Average duration of ET at time of biopsy was 14.54 years (range=3-38). 23/24 (96%) had undergone DaT scans, of which 20/23 (87%) were normal. Of the 20 with normal DaT scans, 17/20 (85%) were positive (+) for P-SYN. Of the 24 ET-P patients, 20/24 (83%) were P-SYN(+), of which 19/20 (95%) had normal DaT scans. 13/24 (54%) had cardiac MIBG scans, of which 8/13 (61%) were abnormal; all 13 had normal DaT scans. 6/8 (75%) with abnormal cardiac MIBG scans were P-SYN(+). 16/24 (67%) ET-P patients had the UPSIT, of which 11/16 (69%) were abnormal. With smokers excluded, only 6/16 (38%) had abnormal UPSIT.

Conclusion: The majority of ET-P patients have evidence of peripheral synucleinopathy despite normal DaT scans. Our preliminary retrospective data suggests skin biopsy for P-SYN may help identify ET-P patients who may be at risk for developing PD, MSA or DLB.

To cite this abstract in AMA style:

VG. Evidente, T. Levine, D. Evidente, R. Freeman, C. Gibbons. Peripheral Synucleinopathy in Essential Tremor Plus Patients with Parkinsonian Features and Normal Dopamine Transporter Imaging [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/peripheral-synucleinopathy-in-essential-tremor-plus-patients-with-parkinsonian-features-and-normal-dopamine-transporter-imaging/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/peripheral-synucleinopathy-in-essential-tremor-plus-patients-with-parkinsonian-features-and-normal-dopamine-transporter-imaging/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley